Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.17
-1.1800-2.39%
Post-market: 48.540.3714+0.77%18:43 EDT
Volume:5.85M
Turnover:284.22M
Market Cap:97.43B
PE:15.40
High:49.05
Open:48.93
Low:48.17
Close:49.35
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.87
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.74%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.16
PE(LYR):12.89

Loading ...

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
6 hours ago

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Yesterday

Jefferies Remains a Buy on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29

GSK Falls Friday, Underperforms Market

Dow Jones
·
Sep 26

Pharmaceutical Stocks Jump. Moderna, Eli Lilly up over 3%; Novavax, Pfizer up Around 2%; Merck, Novo Nordisk up over 1%

Tiger Newspress
·
Sep 24

RBC Capital Keeps Their Hold Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 24

Barclays Sticks to Its Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 23

European Pharma Leaders Push for National Reforms to Boost Investment

Dow Jones
·
Sep 22

GSK Rallies Monday, Outperforms Market

Dow Jones
·
Sep 22

European Equities Traded in the US as American depositary Receipts Rise in Monday Trading

MT Newswires Live
·
Sep 21

Movement Alert|GlaxoSmithKline PLC Falls 3.04% in Regular Trading, Trading at $49.525

Market Focus
·
Sep 18

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 18

GSK Climbs Thursday, Outperforms Market

Dow Jones
·
Sep 18

Positive Report for GlaxoSmithKline (GSK) from Berenberg Bank

TIPRANKS
·
Sep 16

Sector Update: Healthcare

MT Newswires Live
·
Sep 16

Is the Shingles Vaccine the Secret to Living Longer and Delaying Dementia? Here's What the Science Says.

Dow Jones
·
Sep 15

GSK upgraded to Buy from Hold at Berenberg

TIPRANKS
·
Sep 15

GSK Doubles Down On Oncology: Buys Global Rights To Chimagen's Trispecific TCE For Up To $750 Million

Options & Short Sell
·
Sep 15